Chief Technical Operations Officer · Nuvation Bio Inc. (NUVB)

David Hanley

FY2021 is the first fiscal year CompBrief holds for David Hanley as a named executive officer of Nuvation Bio; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$4,819,131

Salary $242,083Stock awards $0Bonus $100,000

1st of 3 named executive officers at Nuvation Bio by FY2021 total.

3 named officers on file for Nuvation Bio, FY2021

David Hanley’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 2 equity grants, each cited to its filing

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Nuvation Bio’s whole pay program stands against its peers

  • Nuvation Bio’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NUVB→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 4, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get David Hanley’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

David Hanley compensation by year

Nuvation Bio Summary Compensation Table · the one fiscal year held
In US dollars, as Nuvation Bio reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$242,083
Bonus$100,000
Stock awards$0
Option awards$4,321,994
Non-equity incentive$145,989
Pension and deferred compensation$0
All other$9,065
Total$4,819,131

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Nuvation Bio Inc. DEF 14A filed April 4, 2022, accession 0001140361-22-012878, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Nuvation Bio Inc. filed document, accession 0001140361-22-012878. Every figure is read from that document and cited to the page and table it appears in. Filed April 4, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option250,000—$13.60
Option187,500—$13.60

Per the Outstanding Equity Awards at Fiscal Year-End table in Nuvation Bio Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

5 Form 4 lines since the FY2021 proxy (filed April 4, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-02-27Grant or award derivative—748,130$0.00748,130
2025-11-19Sale—200,000$7.1424,000
2025-11-19Exercise or conversion—200,000$1.87224,000
2025-11-19Exercise or conversion derivative—200,000$0.00300,000
2025-02-28Grant or award derivative—500,000$0.00500,000

The 5 most recent of 5 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Nuvation Bio’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
David Hanley · this pageChief Technical Operations Officer$4,819,131
David HungPresident and Chief Executive Officer$4,772,385
Jennifer FoxChief Financial Officer$1,006,930

The full Nuvation Bio compensation record

free company brief

This page is one person within Nuvation Bio's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Nuvation Bio's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Hanley's compensation dossier · One-time report. No refunds.